A new study reports a genetically modified poliovirus therapy has been shown to improve long term survival rates in recurrent glioblastoma brain cancer patients. Researchers say the therapy had a three year survival rate for 21 percent of participants in a phase 1 clinical trial, compared to just 4% of patients who received more standard treatments.
A study of 252 professional baseball players revealed those who scored higher on a series of computerized motor and visual tasks had better batting averages and fewer strikeouts than their peers with lower scores.